Abbott Diagnostics GmbH Sustainability Profile
Abbott Diagnostics GmbH, a subsidiary of Abbott Laboratories, is a leading player in the global diagnostics industry, headquartered in Germany. Established in 1888, the company has consistently innovated in the field of medical diagnostics, focusing on areas such as immunoassay, molecular diagnostics, and point-of-care testing. With a strong presence in Europe and beyond, Abbott Diagnostics is renowned for its cutting-edge products, including the ARCHITECT and Alinity systems, which enhance laboratory efficiency and accuracy. The company’s commitment to advancing healthcare through innovative solutions has solidified its market position, making it a trusted partner for healthcare providers worldwide. Abbott Diagnostics continues to set benchmarks in the industry, driven by a legacy of excellence and a focus on improving patient outcomes.
DitchCarbon Score
How does Abbott Diagnostics GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott Diagnostics GmbH's score of 51 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abbott Diagnostics GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Abbott Laboratories, which cascades its climate commitments and targets down to its subsidiaries. Abbott Laboratories has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments, which are relevant to Abbott Diagnostics GmbH. However, specific reduction targets or achievements for Abbott Diagnostics GmbH are not detailed in the available data. As a subsidiary, Abbott Diagnostics GmbH aligns with the broader sustainability goals set by Abbott Laboratories, which may include commitments to reduce greenhouse gas emissions across Scope 1, 2, and 3 categories. The absence of specific emissions data suggests that the company is in the process of developing or implementing its own climate strategies in line with its parent company's initiatives. In summary, while Abbott Diagnostics GmbH does not currently report specific emissions figures, it is part of a corporate family that is actively engaged in climate commitments through Abbott Laboratories, which may influence its future sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
How Carbon Intensive is Abbott Diagnostics GmbH's Industry?
How Carbon Intensive is Abbott Diagnostics GmbH's Location?
Abbott Diagnostics GmbH's Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Abbott Diagnostics GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abbott Diagnostics GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
